HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Duksin, D. Articles by Bornstein, P. Search for Related Content PubMed PubMed Citation Articles by Duksin, D. Articles by Bornstein, P. Social Bookmarking                      What's this?

JBC, Vol. 252, Issue 3, 955-962, Feb, 1977

Impaired conversion of procollagen to collagen by fibroblasts and bone treated with tunicamycin, an inhibitor of protein glycosylation

D. Duksin and P. Bornstein

Tunicamycin, an inhibitor of lipid carrier-dependent protein glycosylation, was used in studies of procollagen synthesis, secretion, and proteolytic modification by chick cranial bones in organ culture and by chick tendon fibroblasts in tissue culture. Tunicamycin inhibited the incorporation of D-[2-3H]mannose into procollagen by greater than 90% whereas general protein synthesis and collagen synthesis were decreased by only 10 to 20%. The procollagen synthesized in the presence of tunicamycin was secreted normally and its immunological characteristics, as detected by an antiserum to the intact protein, were unchanged. However, tunicamycin caused an accumulation of biosynthetic intermediates containing disulfide-bonded COOH-terminal extensions in both cell and bone culture. Cleavage of NH2-terminal extensions was not detectably impaired. These findings provide additional support for the involvement of more than one enzyme in the limited proteolytic conversion of procollagen to collagen.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. R. Lamand and J. F. Bateman The Type I Collagen pro[IMAGE]1(I) COOH-terminal Propeptide N-Linked Oligosaccharide J. Biol. Chem., July 28, 1995; 270(30): 17858 - 17865. [Abstract] [Full Text] [PDF]

				R. Maheshwari, T Sreevalsan, R. Silverman, J Hay, and R. Friedman Tunicamycin enhances the antiviral and anticellular activity of interferon Science, March 18, 1983; 219(4590): 1339 - 1341. [Abstract] [PDF]

				D. Sabatini, D. Colman, E. Sabban, J. Sherman, T. Morimoto, G. Kreibich, and M. Adesnik Mechanisms for the Incorporation of Proteins into the Plasma Membrane Cold Spring Harb Symp Quant Biol, January 1, 1982; 46(0): 807 - 818. [Abstract] [PDF]